Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ayusawa

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Somatic Cell Genetics|September 1, 1981
Selection of mammalian thymidine auxotrophic cell mutants defective in thymidylate synthase by their reduced sensitivity to methotrexateD Ayusawa, H Koyama, K Iwata, et al.
FEBS Letters|June 3, 1985
Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsJ Balzarini, E de Clercq, D Ayusawa, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1985
Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell lineJ Balzarini, E De Clercq, D Ayusawa, et al.
The Biochemical Journal|January 1, 1984
Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNAJ Balzarini, E De Clercq, D Ayusawa, et al.
FEBS Letters|July 23, 1984
Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitorsJ Balzarini, E de Clercq, D Ayusawa, et al.
Japanese Journal of Cancer Research : Gann|October 1, 1985
Expression of fragile site on the human X chromosome in somatic cell hybrids between human fragile X cells and thymidylate synthase-negative mouse mutant cellsT Hori, D Ayusawa, T W Glover, et al.
The Journal of Biological Chemistry|October 25, 1983
Accumulation of DNA strand breaks during thymineless death in thymidylate synthase-negative mutants of mouse FM3A cellsD Ayusawa, K Shimizu, H Koyama, et al.
Biochemical and Biophysical Research Communications|December 14, 1979
Increase in dATP pool in aphidicolin-resistant mutants of mouse FM3A cellsD Ayusawa, K Iwata, T Kozu, et al.
Somatic Cell and Molecular Genetics|May 1, 1985
Assignment of human gene encoding thymidylate synthase to chromosome 18 using interspecific cell hybrids between thymidylate synthase-negative mouse mutant cells and human diploid fibroblastsT Hori, D Ayusawa, K Shimizu, et al.
Journal of Biochemistry|May 1, 1984
Molecular cloning of genomic DNA segments partially coding for human thymidylate synthase from the mouse cell transformantK Takeishi, D Ayusawa, S Kaneda, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Somatic Cell Genetics|September 1, 1981
Selection of mammalian thymidine auxotrophic cell mutants defective in thymidylate synthase by their reduced sensitivity to methotrexateD Ayusawa, H Koyama, K Iwata, et al.
FEBS Letters|June 3, 1985
Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compoundsJ Balzarini, E de Clercq, D Ayusawa, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1985
Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell lineJ Balzarini, E De Clercq, D Ayusawa, et al.
The Biochemical Journal|January 1, 1984
Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNAJ Balzarini, E De Clercq, D Ayusawa, et al.
FEBS Letters|July 23, 1984
Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitorsJ Balzarini, E de Clercq, D Ayusawa, et al.
Japanese Journal of Cancer Research : Gann|October 1, 1985
Expression of fragile site on the human X chromosome in somatic cell hybrids between human fragile X cells and thymidylate synthase-negative mouse mutant cellsT Hori, D Ayusawa, T W Glover, et al.
The Journal of Biological Chemistry|October 25, 1983
Accumulation of DNA strand breaks during thymineless death in thymidylate synthase-negative mutants of mouse FM3A cellsD Ayusawa, K Shimizu, H Koyama, et al.
Biochemical and Biophysical Research Communications|December 14, 1979
Increase in dATP pool in aphidicolin-resistant mutants of mouse FM3A cellsD Ayusawa, K Iwata, T Kozu, et al.
Somatic Cell and Molecular Genetics|May 1, 1985
Assignment of human gene encoding thymidylate synthase to chromosome 18 using interspecific cell hybrids between thymidylate synthase-negative mouse mutant cells and human diploid fibroblastsT Hori, D Ayusawa, K Shimizu, et al.
Journal of Biochemistry|May 1, 1984
Molecular cloning of genomic DNA segments partially coding for human thymidylate synthase from the mouse cell transformantK Takeishi, D Ayusawa, S Kaneda, et al.
Pageof 10